Chunghwa Chemical Synthesis & Biotech Co., Ltd.
TWSE:1762.TW
42.4 (TWD) • At close September 16, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Chunghwa Chemical Synthesis & Biotech Co., Ltd. |
Symbool | 1762.TW |
Munteenheid | TWD |
Prijs | 42.4 |
Beurswaarde | 3,288,544,000 |
Dividendpercentage | 2.82% |
52-weken bereik | 40.7 - 63.1 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Chung-Hsin Huang |
Website | https://www.ccsb.com.tw |
An error occurred while fetching data.
Over Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (TWD)
Cijfers zijn in miljoenen (TWD)